MeCure Industries

What MeCure Industries does

MeCure Industries PLC is a Lagos-headquartered pharmaceutical manufacturer founded in 2005 and listed on the Nigerian Exchange (NGX) Growth Board under ticker MECURE since November 2023. The company produces over 50 brands and 200+ generic formulations spanning antibiotics, antimalarials, cardiovascular, anti-diabetic, analgesics, multivitamins, and dietary supplements (under the Youthberry brand), manufactured at cGMP-compliant, ISO 9001:2015-certified facilities in Oshodi, Lagos, with multi-format capability across tablets, capsules, dry syrups, stick packs, sachets, and syrups. Proprietary technology includes the GS1-certified Track & Trace system developed with ACG Inspection, which assigns unique 12-digit serial numbers to each product for smartphone-based authentication, and the Liquitab Floatcap tablet-in-capsule formulation.

MeCure operates three revenue streams: (1) direct pharmaceutical product sales to a network of 150+ distributors and pharmacies, supported by four strategically located depots in Lagos, Kano, Onambra/Onitsha, and Abia; (2) the PharmaMart B2B2C e-commerce platform, operated under MeCure Distribution Limited, which sells to wholesalers and pharmacies with credit facilities and free Lagos delivery; and (3) contract manufacturing services for partner companies including TOC Pharma, Venchura Pharmaceutical, High Clout Pharma, and Exxon (Pharmaceutical), covering multiple therapeutic categories and dosage forms. The company's products are sold primarily through its own field sales organization (Medical Sales Representatives, Area Sales Managers, Key Account Managers) and through its distributor network across Nigeria, with stated ambitions for West African expansion.

The company is led by founder and Chairman Samir Udani alongside Co-CEOs Anderline Dukor (Operations) and Arjun Udani (Commercial). In October 2024, Zrosk Investment Management acquired a 10% strategic stake. Recent financial performance has been strong: FY2025 revenue of N77.69 billion (+69% YoY), profit after tax of N6.463 billion (+177.5% YoY), and a 369% YTD stock price gain in 2025 leading the Nigerian pharma sector. MeCure also operates a sister company, MeCure Healthcare Limited, which provides advanced diagnostic services including PET-CT and medical cyclotron facilities in West Africa.

Name

MeCure Industries

Legal name

MeCure Industries PLC

Website

https://mecure.com

Company type

Public

Founded year

2005

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

MeCure Industries PLC is a Nigerian pharmaceutical manufacturer producing 50+ brands of antibiotics, generics, and dietary supplements through cGMP-compliant facilities, selling via 150+ distributors, a PharmaMart B2B2C platform, and contract manufacturing services for partner companies.

Ownership category

akta.pro rank

Headquarters

HQ city

Lagos

HQ country

Nigeria

HQ region

Africa

Offices7 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Product Sales: MeCure generates revenue primarily through the manufacture and sale of pharmaceutical products including branded generics, OTC medicines, and dietary supplements across therapeutic categories including antibiotics, antimalarials, cardiovascular, analgesics, multivitamins, and nutraceuticals. Revenue is derived from sales to distributors, pharmacies, clinics, healthcare providers, and retail customers across Nigeria and West Africa.
2. Contract Manufacturing Services: MeCure provides end-to-end pharmaceutical contract manufacturing solutions for companies seeking reliable production, regulatory discipline, and market-ready execution. Revenue is generated through manufacturing fees charged to partner companies for product development, commercial production, packaging, and regulatory support.
3. PharmaMart B2B2C Platform: PharmaMart, operated under MeCure Distribution Limited, serves as a B2B2C e-commerce platform enabling purchase of pharmaceutical products by distributors, wholesalers, pharmacies, and healthcare providers, with credit facilities and delivery services.
4. Nutraceutical Sales (Youthberry): Sale of dietary supplements and wellness products under the Youthberry brand, including multivitamins and nutritional supplements.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels7 records

Core offering

MeCure Industries PLC is a Nigerian pharmaceutical manufacturer that produces and distributes over-the-counter medicines, branded generic pharmaceuticals, and dietary supplements across therapeutic categories including antibiotics, antimalarials, cardiovascular, analgesics, multivitamins, and nutraceuticals. The company operates cGMP-compliant manufacturing facilities, the PharmaMart B2B2C e-commerce distribution platform under MeCure Distribution Limited, and offers end-to-end contract manufacturing services for third-party pharmaceutical companies.

Product overview

MeCure Industries PLC is a Nigerian pharmaceutical manufacturer operating as a platform business with three core product lines: (1) Pharmaceutical manufacturing of OTC medicines, branded generics, and dietary supplements under the Youthberry brand; (2) PharmaMart, a B2B2C e-commerce platform for online pharmaceutical sales with logistics and credit facilities; (3) Contract manufacturing services for third-party pharmaceutical companies. The company produces 50+ brands across antibiotics (Laclox, Lamox, Augmec), antimalarials (Winmalar, Artemether/Lumefantrine), cardiovascular (Lisin, Amlodipine, Atorvastatin, Losartan), analgesics (Ebu, Lapar, Zapar, Diclofenac), multivitamins (Zevit, Blood Tone, Vita Ace), and other therapeutic categories. A key differentiator is the Track & Trace smartphone authentication system for product anti-counterfeiting, and the company holds ISO 9001:2015 certification with cGMP-compliant manufacturing facilities.

Differentiator

Problem solved

Functional benefit

Brands

• Youthberry: Nutraceutical line of dietary supplements launched in 2016 to promote wellness
• PharmaMart
• Track & Trace
• HelloDoc
• AugMec
• Lamox
• Zevit
• Lapar
• Ebu

Quantifiable outcome

• 369% stock price gain in 2025, leading Nigerian pharma sector and outperforming NGX All-Share Index
• +4 more outcomes

Named customers4 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Eleven partnerships are on record, tiered core, supporting and minor.

• ACG InspectioncoreTechnology or Integration · 8 January 2024MeCure partnered with ACG Inspection, a globally recognized Track & Trace solution provider, to implement a GS1-certified Track & Trace system enabling end-to-end pharmaceutical supply chain monitoring with unique 12-digit serialization and smartphone-based product authentication. The partnership strengthens anti-counterfeiting measures and enhances patient safety standards in Nigeria's pharmaceutical landscape.
• Cordros Registrars LimitedsupportingImplementation/ SI/ Consulting PartnerCordros Registrars provides share registry services to MeCure Industries PLC, managing all registered information relating to shareholdings including shareholder names, addresses, dividend payment instructions, and annual report distribution. Located at 21 Norman Williams Street, Ikoyi, Lagos.
• MeCure Healthcare LimitedcoreStrategic or Co-development PartnerMeCure Healthcare Limited is a sister company of MeCure Industries PLC, providing advanced diagnostic and treatment services across Nigeria. It is the first in West Africa to introduce cutting-edge diagnostic technology including PET-CT and medical cyclotron facilities for comprehensive cancer care and early diagnosis, supporting MeCure's mission to expand healthcare access.
• TOC PharmasupportingChannel Partner/ Reseller/ DistributorContract manufacturing partnership spanning multiple therapeutic categories and dosage forms. TOC Pharma represents one of the trusted pharmaceutical companies MeCure supports through its contract manufacturing services.
• Venchura Pharmaceutical LimitedsupportingChannel Partner/ Reseller/ DistributorContract manufacturing partner for pharmaceutical products supported by MeCure's manufacturing capabilities.
• High Clout Pharma LtdsupportingChannel Partner/ Reseller/ DistributorContract manufacturing partner for pharmaceutical products supported by MeCure's manufacturing capabilities.
• Exxon (Pharmaceutical)supportingChannel Partner/ Reseller/ DistributorContract manufacturing partner for pharmaceutical products across multiple therapeutic categories and dosage forms including antibiotics, anti-infectives, cardiovascular, pain management, oral suspensions, tablets, capsules, and liquid formulations.
• Værdi Investor RelationssupportingImplementation/ SI/ Consulting PartnerVærdi Investor Relations serves as MeCure's investor relations advisers, managing media inquiries, press contact, and corporate communications. Contact: Oluyemisi Lanre-Phillips at [email protected].
• NAFDAC (National Agency for Food and Drug Administration and Control)coreOthersMeCure operates under regulatory oversight of NAFDAC and has collaborated with the agency on Track & Trace implementation. The company acknowledged NAFDAC Director General Prof. Moji Christianah Adeyeye for visionary leadership in advancing Track & Trace solutions for patient safety in Nigeria.
• GS1 NigeriacoreTechnology or IntegrationMeCure's Track & Trace system follows GS1 global standards for pharmaceutical traceability. GS1 Nigeria works with NAFDAC to encourage local manufacturers to implement Track & Trace programs, harmonizing critical tracking events and key data elements across the supply chain.
• Lagos State Waste Management Authority (LAWMA)minorOthersMeCure partners with LAWMA for solid waste separation, packaging, and recycling from production operations, contributing to environmental sustainability and responsible waste management.

Scale indicators13 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• Cipla Limited: Indian global pharmaceutical company with strong presence in Africa including Nigeria, focused on generics across respiratory, antiretroviral, and chronic disease categories. Comparable to MeCure in generic pharmaceutical focus and African market presence, though operates at global scale with broader therapeutic portfolio and stronger R&D capabilities.
• AstraZeneca Nigeria: Nigerian operation of global biopharmaceutical company AstraZeneca focused on cardiovascular, respiratory, and oncology branded medications. Comparable to MeCure as a pharmaceutical player in Nigeria but with a multinational focus on patented originator drugs rather than locally manufactured generics.
• Aspen Pharmacare Holdings Limited: South African-headquartered pan-African pharmaceutical manufacturer with strong presence across Sub-Saharan Africa. Comparable to MeCure in African manufacturing footprint, generic and OTC portfolio, and emerging market distribution strategy, though at significantly larger scale and broader geographic reach.
• GlaxoSmithKline Consumer Nigeria Plc: NGX-listed subsidiary of GSK producing consumer healthcare and OTC products in Nigeria. Comparable to MeCure in the OTC and consumer health segment but operates as part of a global multinational with broader portfolio, deeper marketing budgets, and imported product lines.
• Sanofi-Aventis Nigeria Plc: Nigerian subsidiary of global pharmaceutical company Sanofi manufacturing and distributing branded pharmaceuticals including diabetes, cardiovascular, and vaccines. Comparable to MeCure in the Nigerian pharmaceutical market but operates with imported and locally manufactured innovator and generic products under a global brand.

Emerging players

• Biofem Pharmaceuticals Limited: Nigerian pharmaceutical company focused on antimalarials, antibiotics, and consumer health products. Comparable to MeCure in therapeutic focus and target market but smaller scale and more limited distribution and product breadth.

Direct peers

• Emzor Pharmaceutical Industries Limited: One of Nigeria's largest indigenous pharmaceutical manufacturers with a broad generic portfolio including antibiotics, analgesics, and antimalarials. Comparable to MeCure in therapeutic category coverage, manufacturing scale, and distribution reach via Nigerian wholesalers and pharmacies.
• Fidson Healthcare Plc: Nigerian pharmaceutical manufacturer listed on the NGX producing branded generics, OTC medicines, and consumer health products. Closely comparable to MeCure in product mix (antibiotics, antimalarials, analgesics, multivitamins), distribution model, and target customer base of Nigerian distributors and pharmacies.
• May & Baker Nigeria Plc: NGX-listed Nigerian pharmaceutical manufacturer with a long operating history producing generics, OTC medicines, and consumer healthcare products. Comparable to MeCure in listed status, local manufacturing focus, and therapeutic portfolio breadth across antibiotics, antimalarials, and chronic disease medications.
• Neimeth International Pharmaceuticals Plc: Nigerian pharmaceutical manufacturer and distributor listed on NGX with focus on generics and specialty pharmaceuticals. Comparable to MeCure in product categories (antibiotics, cardiovascular, vitamins), regulatory positioning with NAFDAC, and B2B distribution to Nigerian pharmacies and hospitals.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xtwitter.com/Mecure_ind
• LinkedInlinkedin.com/company/mecureinc

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Subsidiaries2 records

Funding overview

Funding rounds3 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MeCure Industries